BASi Elects Neff to Board of Directors
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThe board of directors of Bioanalytical Systems Inc. has elected R. Matthew Neff as a director. He fills the vacancy created by Larry Boulet’s retirement. The board has also appointed Neff chairman of the Audit Committee. He is currently of counsel with Bingham Greenebaum Doll LLP’s Corporate and Transactional Department. From August 2013 through June 2016, Neff served as chairman, president and chief executive officer of AIT Laboratories. He joined AIT Laboratories after his tenure as president and CEO of CHV Capital Inc., the venture capital subsidiary of Indiana University Health, a role he had held since 2007.
Neff started his career as a practicing lawyer and Partner at Baker & Daniels. He then served as deputy to the chairman of the Federal Housing Finance Board (now known as the Federal Housing Finance Agency) in the first Bush Administration. Thereafter, he became the co-founder and CEO of two Indianapolis companies: Circle Investors, an insurance holding company then chaired by former vice president of the United States, Dan Quayle, and Senex Financial Corp., a healthcare receivables finance company. Neff currently serves on the board of directors of Fairbanks Addiction Treatment Center and was a member of Riley Children’s Foundation’s board of directors.
He earned his bachelor’s degree and graduated a Phi Beta Kappa from DePauw University. Neff also received his Juris Doctor degree from Indiana University School of Law, where he was executive editor of the Indiana Law Review.